Sabby Management’s Lunai Bioworks LNAI Stock Holding History

Sabby Management’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-991	Closed	-$534K	–	210
2021 Q3	$534K	Sell	991 -15,780	-94%	-$7.71M	0.07%	115
2021 Q2	$6.67M	Buy	+16,771	New	+$5.46M	0.94%	11

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management's LNAI Position: Q4 2021 in Review

Sabby Management sold out of Lunai Bioworks (LNAI) in Q4 2021, closing a stake of 991 shares — an estimated $534K sold.

Sabby Management first reported a position in LNAI in Q2 2021 and held it in 2 quarters. The position peaked at $6.67M in Q2 2021. 44 funds tracked by Wall St. Rank hold LNAI as of Q4 2021.

Sabby Management reported no remaining Lunai Bioworks position as of Q4 2021 after selling out during the quarter.
Sabby Management sold 991 Lunai Bioworks shares in Q4 2021, an estimated $534K.
Sabby Management first reported a position in Lunai Bioworks in Q2 2021 and held it in 2 quarters.
Sabby Management's Lunai Bioworks position peaked at $6.67M in Q2 2021.
44 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2021.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.